Previous 10 | Next 10 |
Business Wire news releases related Globe And Mail news releases and Globe And Mail press releases from 08/24/23 04:05:00 on US and Canada Markets.
Appropriate payment amounts received on two MyoPro claims; Additional claims are under review while CMS rulemaking to re-classify the MyoPro to the brace benefit category progresses Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable m...
LAKEWOOD, Colo., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories Inc (Nasdaq: MLAB; “Mesa” or the “Company”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced its commitment to calculate a...
- IPX203 demonstrated statistically significant improvement in daily “Good On” time compared to optimized IR CD/LD, with fewer daily doses Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that JAMA Neurology has published results from the RISE-PD clinical study ...
REV Group (NYSE: REVG), today announced that it is planning to release its third quarter fiscal 2023 results before market open on Wednesday, September 13, 2023. The results will be discussed during a live webcast later that morning on September 13, 2023, beginning at 10:00 a.m. ET. To access the...
HERZLIYA, Israel and SAN FRANCISCO, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Otonomo Technologies Ltd. (Nasdaq: OTMO) (“Otonomo” or the “Company”), the platform powering the mobility economy, today announced its financial and operational results for the quarter ended June...
HERZLIYA, Israel and SAN FRANCISCO, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Otonomo Technologies Ltd. (Nasdaq: OTMO) (“Otonomo” or the “Company”), the platform powering the mobility economy, today announced its financial and operational results for the quarter ended June...
Workday Announces Fiscal 2024 Second Quarter Financial Results PR Newswire Fiscal Second Quarter Total Revenues of $1.79 Billion , Up 16.3% Year Over Year Subscription Revenues of $1.62 Billion , Up 18.8% Year Over Year 24-Month Subscription Revenue Backlog...
Phase 1/2a clinical trial of tetraspecific T cell engager candidate MP0533 initiated in patients with relapsed/refractory AML and MDS/AML; dosing ongoing in the 4th dose cohort; initial data expected in Q4 2023 Positive MP0317 data of ongoing Phase 1 clinical trial presented at ASCO con...
Lam Research Appoints General Electric Alum John M. Dineen to Board of Directors PR Newswire FREMONT, Calif. , Aug. 24, 2023 /PRNewswire/ -- Lam Research Corp. (NASDAQ: LRCX) today announced that John M. Dineen has joined its board of directors, effective...
Full year revenue grew 13 percent, Small Business and Self-Employed Group revenue grew 24 percent Intuit Inc. (NASDAQ: INTU), the global financial technology platform that makes TurboTax , Credit Karma , QuickBooks , and Mailchimp , announced financial results for th...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
22.84%Change Percent:
Siyata Mobile Inc. Company Name:
SYTA Stock Symbol:
NASDAQ Market:
siyatamobile.com Website: